ChemicalBook >> CAS DataBase List >>GLP-1 receptor agonist 1

GLP-1 receptor agonist 1

CAS No.
2212020-52-3
Chemical Name:
GLP-1 receptor agonist 1
Synonyms
LY3502970;OWL 833;Orforglipron;Orforglipron(LY3502970);LY3502970 (Orforglipron);Orforglipron, 10 mM in DMSO;Research Grade Orforglipron;GLP-1 receptor agonist 1 USP/EP/BP;LY3502970|||GLP-1 receptor agonist 1;1,2,4-Oxadiazol-5(2H)-one,3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazChemicalbookol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H
CBNumber:
CB45419742
Molecular Formula:
C48H48F2N10O5
Molecular Weight:
882.97
MDL Number:
MOL File:
2212020-52-3.mol
Last updated:2025-04-17 18:22:24

GLP-1 receptor agonist 1 Properties

Density 1.50±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : 125 mg/mL (141.57 mM)
form Solid
pka 7.33±0.20(Predicted)
color Off-white to light yellow
InChIKey USUWIEBBBWHKNI-BBGRWQLENA-N
FDA UNII 7ZW40D021M

GLP-1 receptor agonist 1 price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0043632 GLP-1receptoragonist1 99.42% 2212020-52-3 5mg $1100 2021-12-16 Buy
ChemScene CS-0043632 GLP-1receptoragonist1 99.42% 2212020-52-3 10mg $1800 2021-12-16 Buy
ChemScene CS-0043632 GLP-1receptoragonist1 99.42% 2212020-52-3 25mg $3900 2021-12-16 Buy
ChemScene CS-0043632 GLP-1receptoragonist1 99.42% 2212020-52-3 50mg $6500 2021-12-16 Buy
ChemScene CS-0043632 GLP-1receptoragonist1 99.42% 2212020-52-3 100mg $9950 2021-12-16 Buy
Product number Packaging Price Buy
CS-0043632 5mg $1100 Buy
CS-0043632 10mg $1800 Buy
CS-0043632 25mg $3900 Buy
CS-0043632 50mg $6500 Buy
CS-0043632 100mg $9950 Buy

GLP-1 receptor agonist 1 Chemical Properties,Uses,Production

Description

Orforglipron (LY3502970) (GLP-1 receptor agonist 1) is  GLP-1 receptor agonist extracted from patent WO2018056453A1, Compound 67.

Uses

Glucagon-like peptide-1 (GLP-1) agonists (also known as GLP-1 receptor agonists, incretin mimetics, or GLP-1 analogs) represent a class of medications used to treat type 2 diabetes mellitus and, in some cases, obesity.

in vivo

Orforglipron (0.94-4.8 nM in plasma concentration, i.v., or 0.05-0.1 mg/mL, i.g. for 5 days) suppresses food intake in a dose-dependent manner, promotes insulin secretion and decreases blood glucose in cynomolgus monkey model[1].
Orforglipron (0.05-1.35 mg/kg, i.g.) reaches Cmax 2 hours after administration at all doses, exhibits proportional ratio of increase in plasma drug exposure to dose increase, indicates a dose-dependent absorption in the gastrointestinal tract[1].

Pharmacokinetic Analysis of Orforglipron in cynomolgus monkey [1]

routeDose (mg/kg)Tmax (h)Cmax (ng/mL)AUC0-24h (ng·h/mL)
i.g.0.052.04.7823.7
i.g.0.152.020.7135
i.g.0.452.032.0208
i.g.1.352.01481040
Animal Model:cynomolgus monkey model[1]
Dosage:0.9-4.8 nM; 0.05-0.1 mg/mL
Administration:continuous i.v. administration for 30 minutes until a plasma concentration of 0.9-4.8 nM at steady state;
i.g. for 5 days with dose of 0.05-0.1 mg/mL
Result:Increased insulin secretion and decreased plasma-glucose. Suppressed food intake in a dose-dependent manner.

GLP-1 receptor agonist 1 Preparation Products And Raw materials

Raw materials

Preparation Products

GLP-1 receptor agonist 1 Suppliers

Global( 128)Suppliers
Supplier Tel Email Country ProdList Advantage
Shanghai Guangyang Jiali Biotechnology Co., Ltd
13407521611 46993711@qq.com China 176 58
Jinan Jianfeng Chemical Co., Ltd
+86-0531-88110457 +86-15562555968 info@pharmachemm.com China 334 58
Senova Technology Co. Ltd.
+86-0755-86703119 +8618503098836 info@senovatech.com China 351 58
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 33024 60
Jinan Carbotang Biotech Co.,Ltd.
+8615866703830 figo.gao@foxmail.com China 8497 58
Accela ChemBio Inc.
+1-858-6993322 info@accelachem.com United States 19825 58
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19552 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 32202 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 22854 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10473 58

View Lastest Price from GLP-1 receptor agonist 1 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Orforglipron pictures 2025-04-28 Orforglipron
2212020-52-3
US $0.00-0.00 / mg 1mg 99% 5000box Jinan Jianfeng Chemical Co., Ltd
GLP-1 receptor agonist 1 pictures 2025-04-27 GLP-1 receptor agonist 1
2212020-52-3
US $11.00-1.00 / g 1g 99 10000 S&Y Biochem Co.,Ltd
Orforglipron pictures 2024-08-13 Orforglipron
2212020-52-3
US $0.00-0.00 / g 1g 98% 10kg Senova Technology Co. Ltd.
  • Orforglipron pictures
  • Orforglipron
    2212020-52-3
  • US $0.00-0.00 / mg
  • 99%
  • Jinan Jianfeng Chemical Co., Ltd
  • Orforglipron pictures
  • Orforglipron
    2212020-52-3
  • US $0.00-0.00 / g
  • 98%
  • Senova Technology Co. Ltd.

2212020-52-3(GLP-1 receptor agonist 1)Related Search:

1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcy... GLP-1 receptor agonist 1 USP/EP/BP LY3502970 Orforglipron Orforglipron(LY3502970) LY3502970 (Orforglipron) 3-((1S,2S)-1-(5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one OWL 833 LY3502970|||GLP-1 receptor agonist 1 3-((1S,2S)-1-(5-((S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl 1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcyclopropyl]- Orforglipron, 10 mM in DMSO Research Grade Orforglipron 1,2,4-Oxadiazol-5(2H)-one,3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazChemicalbookol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcy 1,2,4-Oxadiazol-5(2H)-one,3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazChemicalbookol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H 2212020-52-3 C48H48F2N10O5 1